
Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
International Journal of Stroke (IJS) recently shared a post on X:
”Just Accepted!
Study finds hemorrhagic transformation was associated with onset-to-imaging time and presence of severe hypoperfusion. No interaction found between time and severe hypoperfusion.”
Read the full article here.
A new study is reinforcing the importance of timely management of stroke in an article ‘Association between Time and Severe Hypoperfusion with Risk of Hemorrhagic Transformation in Stroke Patients’ by Umberto Pensato et al., published in International Journal of Stroke (IJS).
Emerging evidence highlights that both severe hypoperfusion and time spent in a hypoperfused state contribute to the risk of parenchymal hematoma (PH) in ischemic stroke.
A recent analysis confirms that while each factor independently increases the likelihood of hemorrhagic transformation (HT), their interaction was not statistically significant.
These findings suggest that the risk of HT is influenced by distinct pathways related to hypoperfusion severity and duration.
Identifying patients with a “leaky core”—those with severely compromised blood-brain barriers—could enhance patient selection for targeted interventions!
Hemostasis Today, your daily update on scientific advancements in the World of Stroke.
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 16, 2025, 15:00Together with Dr. Bethany Samuelson Bannow – Let’s Keep Hematology Moving Forward
-
Jul 16, 2025, 14:58Donate Today to Advance Thrombosis Awareness and Research
-
Jul 16, 2025, 14:57ISTH SSC Launches Survey on Antithrombotic Therapy in Brain Tumor Patients
-
Jul 16, 2025, 14:52ASH Expands Access to Educational Resources in LMICs
-
Jul 16, 2025, 11:06Why Pain Feels Different for Everyone - The Guardian
-
Jul 15, 2025, 18:24Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
-
Jul 15, 2025, 15:48Managing CVT in Pregnancy: Balancing Risks and the Role of Antithrombotic Prophylaxis
-
Jul 15, 2025, 07:37Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding - Blood Journals Portfolio
-
Jul 14, 2025, 18:253 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems